KMT2A Polyklonaler Antikörper

KMT2A Polyklonal Antikörper für WB, Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human

Anwendung

WB, Indirect ELISA

Konjugation

Unkonjugiert

Kat-Nr. : 29278-1-PBS

Synonyme

MLL, HTRX, HRX, FLJ11783, CXXC7



Geprüfte Anwendungen

Produktinformation

29278-1-PBS bindet in WB, Indirect ELISA KMT2A und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Kaninchen / IgG
Klonalität Polyklonal
Typ Antikörper
Immunogen KMT2A fusion protein Ag30468
Vollständiger Name myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila)
Berechnetes Molekulargewicht 432 kDa
Beobachtetes Molekulargewicht180 kDa
GenBank-ZugangsnummerNM_001197104
Gene symbol MLL
Gene ID (NCBI) 4297
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Antigen-Affinitätsreinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

KMT2A, also known as mixed-lineage leukemia (MLL), is a gene that encodes a lysine methyltransferase responsible for the transcriptional activation through lysine 4 of histone 3 (H3K4) methylation. KMT2A is expressed mainly in the nucleus and is ubiquitously present in various tissues, particularly in ovary, lymph node, endometrium, thyroid, and brain tissue. It plays a significant role in embryonic development, hematopoiesis, and neurodevelopment. Mutations in KMT2A have been associated with several pathological conditions.